MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare.Its products include EpiFix, a semi-permeable protective barrier membrane product used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers and pressure ulcers. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors.
